PGC-1α over-expression suppresses the skeletal muscle atrophy and myofiber-type composition during hindlimb unloading
收藏DataCite Commons2025-06-01 更新2024-07-25 收录
下载链接:
https://tandf.figshare.com/articles/dataset/PGC-1_over-expression_suppresses_the_skeletal_muscle_atrophy_and_myofiber-type_composition_during_hindlimb_unloading/4244984/1
下载链接
链接失效反馈官方服务:
资源简介:
Disuse leads to severe muscle atrophy and a slow-to-fast myofiber-type transition. PGC-1α (Peroxisome proliferator-activated receptor <i>γ</i> coactivator 1α) is documented to play an important role in muscle atrophy and slow-twitch myofiber determination. Transcription of atrophy-related Atrogin-1 by FoxO3 can be reduced by PGC-1α. While Smad3 augments FoxO3-induced Atrogin-1 and MuRF1 promoter activity. So PGC-1α, as a transcription co-activator, may regulate hindlimb unloading (HU)-induced myofiber-type transition and muscle atrophy through Smad3. Our results showed that transgenic PGC-1α mice resisted HU-induced muscle loss, atrophy-related genes expression, and slow-to-fast myofiber<sub>-</sub>type transition. Furthermore, over-expression of PGC-1α resisted the increase in pSmad3 during muscle atrophy <i>in vivo</i> and <i>in vitro</i>. And, PGC-1α over-expression inhibited the expression of atrogenes via suppressing the phosphorylation of Smad3 <i>in vitro</i>. Thus, PGC-1α is effective in regulating myofiber-type transition during HU, and it alleviates skeletal muscle atrophy partially through suppressing the activation of Smad3. PGC-1α overexpression alleviates HU-induced myofiber-type transition and may attenuate muscle atrophy partially via suppressing pSmad3.
废用可引发严重的肌肉萎缩,并伴随肌纤维类型从慢肌表型向快肌表型的转变。过氧化物酶体增殖物激活受体γ辅激活因子1α(PGC-1α,Peroxisome proliferator-activated receptor γ coactivator 1α)已被证实,在肌肉萎缩及慢肌肌纤维分型调控中发挥关键作用。叉头框O3(FoxO3)介导的萎缩相关基因Atrogin-1的转录可被PGC-1α抑制;而Smad3则可增强FoxO3诱导的Atrogin-1与肌肉环指蛋白1(MuRF1)的启动子活性。因此,作为转录辅激活因子的PGC-1α,或可通过Smad3通路,调控后肢去负荷(HU,hindlimb unloading)诱导的肌纤维类型转变与肌肉萎缩。本研究结果显示,PGC-1α转基因小鼠可抵抗HU诱导的肌肉丢失、萎缩相关基因表达异常上调,以及慢肌向快肌的肌纤维类型转变。进一步实验证实,在体内(in vivo)与体外(in vitro)模型中,PGC-1α过表达均可抑制肌肉萎缩过程中磷酸化Smad3(pSmad3)水平的升高。此外,体外实验表明,PGC-1α过表达可通过抑制Smad3的磷酸化,下调萎缩相关基因的表达。综上,PGC-1α可有效调控HU过程中的肌纤维类型转变,并可通过抑制Smad3的激活,部分缓解骨骼肌萎缩。PGC-1α过表达可减轻HU诱导的肌纤维类型转变,并可通过抑制pSmad3通路,部分改善肌肉萎缩。
提供机构:
Taylor & Francis
创建时间:
2016-11-21



